SNG.L
Price:
$4.5
Market Cap:
$9.06M
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2004-10-26
Stock Exchange
LSE
Ticker
SNG.L
According to Synairgen plc’s latest financial reports and current stock price. The company's current Current Ratio is 9.76. This represents a change of 19.27% compared to the average of 8.18 of the last 4 quarters.
The mean historical Current Ratio of Synairgen plc over the last ten years is 10.00. The current 9.76 Current Ratio has changed 9.66% with respect to the historical average. Over the past ten years (40 quarters), SNG.L's Current Ratio was at its highest in in the December 2020 quarter at 25.88. The Current Ratio was at its lowest in in the September 2008 quarter at 0.
Average
10.00
Median
7.71
Minimum
2.07
Maximum
25.88
Discovering the peaks and valleys of Synairgen plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.15%
Maximum Annual Current Ratio = 25.88
Minimum Annual Increase = -77.53%
Minimum Annual Current Ratio = 2.07
Year | Current Ratio | Change |
---|---|---|
2023 | 9.01 | 25.31% |
2022 | 7.19 | 23.67% |
2021 | 5.81 | -77.53% |
2020 | 25.88 | 1.15% |
2019 | 2.07 | -74.88% |
2018 | 8.24 | 19.48% |
2017 | 6.89 | 8.40% |
2016 | 6.36 | -27.26% |
2015 | 8.74 | -55.88% |
2014 | 19.82 | 425.45% |
The current Current Ratio of Synairgen plc (SNG.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.34
5-year avg
9.99
10-year avg
10.00
Synairgen plc’s Current Ratio is greater than Omega Diagnostics Group PLC (4.29), greater than Avacta Group Plc (1.29), greater than Novacyt S.A. (4.04), greater than genedrive plc (1.63), greater than Greatland Gold plc (4.40),
Company | Current Ratio | Market cap |
---|---|---|
4.29 | $4.94M | |
1.29 | $190.99M | |
4.04 | $39.94M | |
1.63 | $13.01M | |
4.40 | $645.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synairgen plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synairgen plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Synairgen plc's Current Ratio?
How is the Current Ratio calculated for Synairgen plc (SNG.L)?
What is the highest Current Ratio for Synairgen plc (SNG.L)?
What is the 3-year average Current Ratio for Synairgen plc (SNG.L)?
What is the 5-year average Current Ratio for Synairgen plc (SNG.L)?
How does the current Current Ratio for Synairgen plc (SNG.L) compare to its historical average?